Amedisys, Inc. (NASDAQ:AMED) Sees Large Increase in Short Interest

Amedisys, Inc. (NASDAQ:AMED) was the target of a significant increase in short interest during the month of November. As of November 30th, there was short interest totalling 2,590,000 shares, an increase of 18.8% from the November 15th total of 2,180,000 shares. Approximately 8.1% of the company’s shares are short sold. Based on an average daily volume of 488,500 shares, the days-to-cover ratio is presently 5.3 days.

Institutional Investors Weigh In On Amedisys

A number of hedge funds have recently made changes to their positions in AMED. KBC Group NV bought a new stake in shares of Amedisys in the 3rd quarter valued at about $63,000. Innealta Capital LLC acquired a new position in Amedisys during the 2nd quarter valued at about $64,000. Signaturefd LLC boosted its holdings in Amedisys by 88.2% in the second quarter. Signaturefd LLC now owns 1,131 shares of the health services provider’s stock worth $104,000 after acquiring an additional 530 shares in the last quarter. CWM LLC increased its holdings in shares of Amedisys by 14.5% during the third quarter. CWM LLC now owns 2,190 shares of the health services provider’s stock valued at $211,000 after acquiring an additional 277 shares in the last quarter. Finally, Crossmark Global Holdings Inc. purchased a new position in shares of Amedisys in the 3rd quarter valued at approximately $243,000. 94.36% of the stock is currently owned by hedge funds and other institutional investors.

Amedisys Stock Performance

Amedisys stock opened at $85.68 on Monday. Amedisys has a fifty-two week low of $84.06 and a fifty-two week high of $98.95. The company has a market capitalization of $2.81 billion, a PE ratio of 34.00, a P/E/G ratio of 1.84 and a beta of 0.73. The company has a 50 day moving average price of $92.66 and a 200-day moving average price of $94.93. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.19 and a current ratio of 1.19.

Amedisys (NASDAQ:AMED) last posted its earnings results on Wednesday, November 6th. The health services provider reported $1.00 EPS for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.19). The business had revenue of $587.67 million for the quarter, compared to analysts’ expectations of $586.75 million. Amedisys had a net margin of 3.57% and a return on equity of 12.20%. The company’s revenue for the quarter was up 5.7% on a year-over-year basis. During the same period last year, the business posted $0.98 EPS. As a group, equities analysts forecast that Amedisys will post 4.45 earnings per share for the current year.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.